poisar

Stock

Sagimet Biosciences Inc. SGMT

$7.04-3.16%

Overview

SGMT market data

Price History

SGMT price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.58
Diluted earnings per share over the trailing twelve months.
Beta
3.43
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$4.50 – $10.46
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $430.7 · P/B 1.65.

Company News

7 captured
8-K filing — Sagimet Biosciences Inc. (SGMT)SEC EDGAR · Jul 21, 2026, 1:35 AM
Sagimet Biosciences Added To Broad-Market Russell 3000 Index And Small-Cap Russell 2000 IndexBenzinga · Jun 29, 2026, 11:20 AM
Sagimet Biosciences Joins the Russell 2000® and Russell 3000® IndexesGlobenewswire Inc · Jun 29, 2026, 11:15 AM
Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionBenzinga · Jun 18, 2026, 12:05 PM
UK's MHRA Says Resmetirom (Rezdiffra) Authorized To Treat Metabolic Dysfunction-Associated Steatohepatitis In AdultsBenzinga · Jun 3, 2026, 3:35 PM
Sagimet Biosciences Presents Two Posters At EASL 2026; Denifanstat/Resmetirom Phase 1 Data Selected As Best Of EASL, With Additional Preclinical Mechanism Findings ShowcasedBenzinga · May 27, 2026, 11:16 AM
Citizens Maintains Market Outperform on Sagimet Biosciences, Lowers Price Target to $12Benzinga · May 19, 2026, 12:55 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Sagimet Biosciences Inc. (SGMT) stock — price, valuation & news | Poisar